Natera Total Liabilities 2014-2025 | NTRA
Natera total liabilities from 2014 to 2025. Total liabilities can be defined as the total value of all possible claims against the corporation.
- Natera total liabilities for the quarter ending September 30, 2025 were $0.569B, a 20.09% decline year-over-year.
- Natera total liabilities for 2024 were $0.465B, a 31.2% decline from 2023.
- Natera total liabilities for 2023 were $0.676B, a 1.79% decline from 2022.
- Natera total liabilities for 2022 were $0.689B, a 18.1% increase from 2021.
|
Natera Annual Total Liabilities (Millions of US $) |
|
|---|---|
| 2024 | $465 |
| 2023 | $676 |
| 2022 | $689 |
| 2021 | $583 |
| 2020 | $446 |
| 2019 | $304 |
| 2018 | $236 |
| 2017 | $189 |
| 2016 | $104 |
| 2015 | $80 |
| 2014 | $54 |
| 2013 | $46 |
|
Natera Quarterly Total Liabilities (Millions of US $) |
|
|---|---|
| 2025-09-30 | $569 |
| 2025-06-30 | $511 |
| 2025-03-31 | $493 |
| 2024-12-31 | $465 |
| 2024-09-30 | $712 |
| 2024-06-30 | $680 |
| 2024-03-31 | $674 |
| 2023-12-31 | $676 |
| 2023-09-30 | $662 |
| 2023-06-30 | $652 |
| 2023-03-31 | $668 |
| 2022-12-31 | $689 |
| 2022-09-30 | $647 |
| 2022-06-30 | $622 |
| 2022-03-31 | $602 |
| 2021-12-31 | $583 |
| 2021-09-30 | $552 |
| 2021-06-30 | $551 |
| 2021-03-31 | $521 |
| 2020-12-31 | $446 |
| 2020-09-30 | $441 |
| 2020-06-30 | $419 |
| 2020-03-31 | $300 |
| 2019-12-31 | $304 |
| 2019-09-30 | $296 |
| 2019-06-30 | $290 |
| 2019-03-31 | $256 |
| 2018-12-31 | $236 |
| 2018-09-30 | $221 |
| 2018-06-30 | $216 |
| 2018-03-31 | $223 |
| 2017-12-31 | $189 |
| 2017-09-30 | $174 |
| 2017-06-30 | $108 |
| 2017-03-31 | $102 |
| 2016-12-31 | $104 |
| 2016-09-30 | $102 |
| 2016-06-30 | $97 |
| 2016-03-31 | $84 |
| 2015-12-31 | $80 |
| 2015-09-30 | $56 |
| 2015-06-30 | $64 |
| 2015-03-31 | $0 |
| 2014-12-31 | |
| 2014-09-30 | $0 |
| 2014-06-30 | $0 |
| 2013-12-31 | $46 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $28.526B | $1.697B |
| Natera, Inc. offers genetic testing and diagnostics with proprietary bioinformatics and molecular technology. Natera, Inc. is headquartered in San Carlos, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $150.156B | 27.25 |
| HCA Healthcare (HCA) | United States | $120.821B | 19.12 |
| CVS Health (CVS) | United States | $99.843B | 11.63 |
| Elevance Health (ELV) | United States | $76.540B | 11.49 |
| Cencora (COR) | United States | $70.193B | 22.08 |
| Labcorp Holdings (LH) | United States | $23.430B | 17.86 |
| DiDi Global (DIDIY) | China | $21.650B | 20.00 |
| Viatris (VTRS) | United States | $18.163B | 6.77 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $15.306B | 0.00 |
| BioMerieux (BMXMF) | France | $13.324B | 0.00 |
| Solventum (SOLV) | United States | $13.104B | 12.72 |
| Medpace Holdings (MEDP) | United States | $12.148B | 27.98 |
| Revvity (RVTY) | United States | $10.887B | 18.94 |
| CochLear (CHEOY) | Australia | $9.243B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.941B | 15.29 |
| ICON (ICLR) | Ireland | $7.510B | 7.45 |
| Sonic Healthcare (SKHHY) | Australia | $7.449B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $7.008B | 41.78 |
| HealthEquity (HQY) | United States | $6.312B | 23.60 |
| Avantor (AVTR) | United States | $6.275B | 10.11 |
| Bausch + Lomb (BLCO) | Canada | $6.034B | 39.60 |
| PACS (PACS) | United States | $5.922B | 36.01 |
| Caris Life Sciences,�Inc (CAI) | United States | $5.818B | 0.00 |
| Sotera Health (SHC) | United States | $4.864B | 23.45 |
| Alignment Healthcare (ALHC) | United States | $4.040B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $3.532B | 20.61 |
| Concentras Parent (CON) | United States | $3.017B | 18.83 |
| GeneDx Holdings (WGS) | United States | $2.606B | 45.76 |
| Establishment Labs Holdings (ESTA) | United States | $2.168B | 0.00 |
| Surgery Partners (SGRY) | United States | $2.000B | 25.77 |
| Organon (OGN) | United States | $1.921B | 2.15 |
| Pediatrix Medical (MD) | United States | $1.848B | 11.04 |
| Progyny (PGNY) | United States | $1.784B | 35.07 |
| Ardent Health (ARDT) | United States | $1.375B | 4.49 |
| InnovAge Holding (INNV) | United States | $1.134B | 167.20 |
| CareDx (CDNA) | United States | $1.010B | 16.50 |
| Teladoc Health (TDOC) | United States | $0.825B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $0.740B | 12.11 |
| Nutex Health (NUTX) | United States | $0.705B | 5.39 |
| Omada Health (OMDA) | United States | $0.655B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.641B | 0.00 |
| Embecta (EMBC) | United States | $0.602B | 3.36 |
| Enhabit (EHAB) | United States | $0.565B | 25.36 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.558B | 0.00 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| SBC Medicals (SBC) | United States | $0.478B | 8.79 |
| CryoPort (CYRX) | United States | $0.418B | 0.00 |
| Strata Critical Medical (SRTA) | United States | $0.396B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.391B | 82.38 |
| Auna S.A (AUNA) | Luxembourg | $0.367B | 5.90 |
| So-Young (SY) | China | $0.328B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.269B | 0.00 |
| Oncology Institute (TOI) | United States | $0.247B | 0.00 |
| Agilon Health (AGL) | United States | $0.150B | 0.00 |
| LifeMD (LFMD) | United States | $0.134B | 0.00 |
| Beauty Health (SKIN) | United States | $0.133B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.109B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.102B | 0.00 |
| Biodesix (BDSX) | United States | $0.091B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.078B | 0.00 |
| DocGo (DCGO) | United States | $0.073B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.041B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.039B | 0.00 |
| Pomdoctor - (POM) | China | $0.026B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.018B | 5.62 |
| OSR Holdings (OSRH) | United States | $0.013B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.012B | 0.00 |
| Lifeward (LFWD) | United States | $0.009B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| XWELL (XWEL) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |